Launched in February 2021, Care2Care International is striving to provide value to healthcare plans and individual patients, and its growth potential is significant. We are looking for investors to help us create jobs, expand our marketing reach, further develop our patient platform, and invest in sourcing partnerships.
During the last decade, drug prices have increased by 84%, outpacing any other medical commodity or service. While brand and specialty drug prices are now 3 to 5 times higher than in other developed countries, this gap continues to grow rapidly! Despite many formal announcements in the last years, no real reform has been put in place and none is realistically in sight.
Meanwhile, every year, over 4 million Americans buy their drugs for personal use abroad. Their rights of importing medications for personal use are protected by Congress, who reiterated its will as recently as 2018, as part of the Opioid Bill.
Contracting with brick-and-mortar pharmacies in Canada and European countries, Care2Care provides an easy access via a patient portal. The pharmacies deliver the medications through mail-order, a solution many Americans are now accustomed to.
Making it safe and easy, Care2care International ambitions to become the premier provider of internationally sourced affordable prescription medications for health plans and individuals while promoting a comprehensive cost-effective pharmacy solution for everyone
Care2Care secured a strategic partnership with an innovative, transparent, 100% pass-through PBM.
Adding to our expertise in international drug sourcing, we expand our offer to the full pharmacy benefit management.
